NO20090579L - Preparater med kontrollerte farmakokinetikker - Google Patents

Preparater med kontrollerte farmakokinetikker

Info

Publication number
NO20090579L
NO20090579L NO20090579A NO20090579A NO20090579L NO 20090579 L NO20090579 L NO 20090579L NO 20090579 A NO20090579 A NO 20090579A NO 20090579 A NO20090579 A NO 20090579A NO 20090579 L NO20090579 L NO 20090579L
Authority
NO
Norway
Prior art keywords
binder
effect
controls
food effect
food
Prior art date
Application number
NO20090579A
Other languages
English (en)
Inventor
Ilan Zalit
Anat Sofer-Raz
Original Assignee
Teva Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Teva Pharma filed Critical Teva Pharma
Publication of NO20090579L publication Critical patent/NO20090579L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • General Preparation And Processing Of Foods (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Oppfinnelsen angår fremgangsmåter for å redusere matens påvirkning på et legemiddel som viser slik matvirkning, ved å fremstille en formulering som omfatter et slikt legemiddel og minst ett bionedbrytbart bindemiddel eller lipofilt bindemiddel. Oppfinnelsen angår også en fremgangsmåte for fremstilling av en formulering som har en målrettet matpåvirkning, omfattende (a) å bestemme en målrettet matpåvirkning, og (b) en aktiv farmasøytisk ingrediens som viser matpåvirkning kombineres med en tilstrekkelig mengde av (i) minst ett bionedbrytbart bindemiddel, (ii) minst ett lipofilt bindemiddel, eller (iii) kombinasjoner derav.
NO20090579A 2006-07-06 2009-02-05 Preparater med kontrollerte farmakokinetikker NO20090579L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US81904106P 2006-07-06 2006-07-06
PCT/US2007/015593 WO2008005543A2 (en) 2006-07-06 2007-07-06 Compositions with controlled pharmacokinetics

Publications (1)

Publication Number Publication Date
NO20090579L true NO20090579L (no) 2009-02-05

Family

ID=38739986

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20090579A NO20090579L (no) 2006-07-06 2009-02-05 Preparater med kontrollerte farmakokinetikker

Country Status (9)

Country Link
EP (1) EP2037894A2 (no)
JP (1) JP2009542693A (no)
KR (1) KR20090017668A (no)
CN (1) CN101484144A (no)
CA (1) CA2654529A1 (no)
IL (1) IL195542A0 (no)
MX (1) MX2008016573A (no)
NO (1) NO20090579L (no)
WO (1) WO2008005543A2 (no)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK2306982T3 (en) * 2008-06-27 2015-04-20 Abdi Ibrahim Ilac Sanayi Ve Ticaret Anonim Sirketi Pharmaceutical compositions of rosuvastatin calcium
US8977133B2 (en) 2012-05-31 2015-03-10 Corning Optical Communications LLC Distributed communications system employing free-space-optical link(S), and related components and methods
IL303390A (en) 2020-12-03 2023-08-01 Battelle Memorial Institute Compositions of polymer nanoparticles and DNA nanostructures and methods for non-viral transport
WO2022216977A1 (en) 2021-04-07 2022-10-13 Batelle Memorial Institute Rapid design, build, test, and learn technologies for identifying and using non-viral carriers
WO2025072751A1 (en) 2023-09-29 2025-04-03 Battelle Memorial Institute Polymer nanoparticle compositions for in vivo expression of polypeptides
AU2024393766A1 (en) 2023-12-08 2026-06-18 Battelle Memorial Institute Use of dna origami nanostructures for molecular information based data storage systems

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1414496B1 (en) * 2001-08-07 2010-10-20 Galephar M/F Pharmaceutical composition containing a combinaition of ppar-alpha, pravastatin and polyglycolized glyceride
US6669955B2 (en) * 2001-08-28 2003-12-30 Longwood Pharmaceutical Research, Inc. Combination dosage form containing individual dosage units of a cholesterol-lowering agent, an inhibitor of the renin-angiotensin system, and aspirin
CA2541382A1 (en) * 2003-10-10 2005-04-21 Lifecycle Pharma A/S A solid dosage form comprising a fibrate and a statin
ES2255426B1 (es) * 2004-10-19 2007-08-16 Gp Pharm, S.A. Formulacion farmaceutica que comprende microcapsulas de estatinas suspendidas en ester alquilicos de acidos grasos poliinsaturados (pufa).

Also Published As

Publication number Publication date
CA2654529A1 (en) 2008-01-10
CN101484144A (zh) 2009-07-15
IL195542A0 (en) 2009-09-01
KR20090017668A (ko) 2009-02-18
WO2008005543A3 (en) 2008-02-14
EP2037894A2 (en) 2009-03-25
MX2008016573A (es) 2009-01-28
WO2008005543A2 (en) 2008-01-10
JP2009542693A (ja) 2009-12-03

Similar Documents

Publication Publication Date Title
CR20110110A (es) Composicion farmaceutica
UA94942C2 (ru) Фармацевтические композиции с ингибиторами dpp iv
BRPI0720972B8 (pt) compostos análogos de ciclopamina e composições farmacêuticas compreendendo os referidos compostos
NO20090797L (no) Farmasoytiske blandinger omfattende kandesartan cileksetil
CY1118099T1 (el) Δισκια οξεικης ουλιπρισταλης
NO20081889L (no) Fast vaksine formulering
NO20072542L (no) Pyrimidinderivat kondensert med ikke-aromatisk ring
NO20080284L (no) Cannabionoid aktiv farmasoytisk ingrediens for forbedrede doseringsformer
TN2009000180A1 (en) NOVEL 1,4-BENZOTHIEPIN-l,1-DIOXIDE DERIVATIVES WHICH ARE SUBSTITUTED WITH BENZYL GROUPS, METHOD FOR PRODUCING DRUGS CONTAINING SAID COMPOUNDS AND USE THEREOF
NO20083104L (no) Fast preparat
CY1119488T1 (el) Παραγων για θεραπεια ή/και αποτροπη διαταραχης υπνου
WO2015017813A3 (en) Inhibitors of the farnesoid x receptor and uses in medicine
EA200700566A1 (ru) Фармацевтические композиции, включающие леветирацетам, и способы их получения
CA2725933A1 (en) Drug combinations comprising a dgat inhibitor and a ppar-agonist
ES2376043T3 (es) Derivados de indazol para el tratamiento de enfermedades inducidas por hsp90.
NO20080220L (no) Formuleringer med hoy medikament belastning og doseringsformer
FR2983409B1 (fr) Comprime susceptible de lutter contre le detournement par voie injectable
CY1113594T1 (el) Φουμαρικο αλας της (αλφα s, βητα r)-6-βρωμο-αλφα-[2-(διμεθυλαμινο)αιθυλ]-2-μεθοξυ-αλφα-1-ναφθαλινυλ-βητα-φαινυλ-3-κινολινοαιθανολης
BR112012014933A2 (pt) composições que compreendem compostos macrocíclicos lactona e spirodioxepinoindóis
UA89315C2 (en) Butylbenzene phthalein intravenous emulsion
NO20083836L (no) N-hydroksyakrylamidforbindelser
IN2014DN08870A (no)
PL1758555T3 (pl) Czynnik tworzący oleożel zawierający triterpen, oleożel zawierający triterpen oraz sposób wytwarzania oleożelu zawierającego triterpen
WO2008004132A3 (en) The vapor-phase application of spinosyn for the control of pests, and formulations and products utilizing the same
EP3760195A4 (en) COMPOSITION WITH 2,3-BUTANEDIOL AS THE ACTIVE SUBSTANCE

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application